메뉴 건너뛰기




Volumn 103, Issue 3, 2000, Pages 162-164

Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE; TUMOR PROTEIN;

EID: 0033643023     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041040     Document Type: Article
Times cited : (16)

References (13)
  • 1
    • 0030869609 scopus 로고    scopus 로고
    • Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA
    • Taniguchi M, Nagaoka K, Kunikata T, Kayano T, Yamauchi H, Nakamura S, Ikeda M, Orita K, Kurimoto M: Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J Immunol Methods 1997;206:107-113.
    • (1997) J Immunol Methods , vol.206 , pp. 107-113
    • Taniguchi, M.1    Nagaoka, K.2    Kunikata, T.3    Kayano, T.4    Yamauchi, H.5    Nakamura, S.6    Ikeda, M.7    Orita, K.8    Kurimoto, M.9
  • 5
    • 0031441994 scopus 로고    scopus 로고
    • A simple and sensitive bioassay for the detection of human interlcukin-18/intcrferongamma-inducing factor using human myelomonocytic KG-1 cells
    • Konishi K, Tanabe F, Taniguchi M, Yamauchi H, Tanimoto T, Ikcda M, Orita K, Kurimoto M: A simple and sensitive bioassay for the detection of human interlcukin-18/intcrferongamma-inducing factor using human myelomonocytic KG-1 cells. J Immunol Methods 1997;209:187-191.
    • (1997) J Immunol Methods , vol.209 , pp. 187-191
    • Konishi, K.1    Tanabe, F.2    Taniguchi, M.3    Yamauchi, H.4    Tanimoto, T.5    Ikcda, M.6    Orita, K.7    Kurimoto, M.8
  • 6
    • 0032144262 scopus 로고    scopus 로고
    • Establishment of the cells useful for murinc interlcukin-18 bioassay by introducing murinc interleukin-18 receptor cDNA into human myelomonocytic KG-1 cells
    • Taniguchi M, Nagaoka K, Ushio S, Nukada Y, Okura T, Mori T, Yamauchi H, Ohta T, Ikcgami H, Kurimoto M: Establishment of the cells useful for murinc interlcukin-18 bioassay by introducing murinc interleukin-18 receptor cDNA into human myelomonocytic KG-1 cells. J Immunol Methods 1998;217:97-102.
    • (1998) J Immunol Methods , vol.217 , pp. 97-102
    • Taniguchi, M.1    Nagaoka, K.2    Ushio, S.3    Nukada, Y.4    Okura, T.5    Mori, T.6    Yamauchi, H.7    Ohta, T.8    Ikcgami, H.9    Kurimoto, M.10
  • 8
    • 0344193088 scopus 로고    scopus 로고
    • Interleukin-18: Perspectives on the newest interlcukin
    • Gillcspic MT, Horwood NJ: Interleukin-18: Perspectives on the newest interlcukin. Cytokine Growth Factor Rev 1998;9:109-116.
    • (1998) Cytokine Growth Factor Rev , vol.9 , pp. 109-116
    • Gillcspic, M.T.1    Horwood, N.J.2
  • 9
    • 15144344777 scopus 로고    scopus 로고
    • Induction of inlcrfcron-Y inducing factor in the adrenal cortex
    • Conli B, Jahng J, Tinti C, Son J, Job T: Induction of inlcrfcron-Y inducing factor in the adrenal cortex. J Biol Chcm 1997;264:2035-2037.
    • (1997) J Biol Chcm , vol.264 , pp. 2035-2037
    • Conli, B.1    Jahng, J.2    Tinti, C.3    Son, J.4    Job, T.5
  • 10
    • 0030777296 scopus 로고    scopus 로고
    • Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2
    • Rothc H, Jcnkins N, Copeland N, Kolb H: Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 1997;99:469-474.
    • (1997) J Clin Invest , vol.99 , pp. 469-474
    • Rothc, H.1    Jcnkins, N.2    Copeland, N.3    Kolb, H.4
  • 12
    • 17544389276 scopus 로고    scopus 로고
    • Interleukin-18 (interfcron-y-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony stimulating factor and not via interfcron-y to inhibit osteoclast formation
    • Udagawa N, Nonvood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillcspie MT: Interleukin-18 (interfcron-y-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony stimulating factor and not via interfcron-y to inhibit osteoclast formation. J ExpMcd 1997;185:1005-1012.
    • (1997) J ExpMcd , vol.185 , pp. 1005-1012
    • Udagawa, N.1    Nonvood, N.J.2    Elliott, J.3    Mackay, A.4    Owens, J.5    Okamura, H.6    Kurimoto, M.7    Chambers, T.J.8    Martin, T.J.9    Gillcspie, M.T.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.